Classically, the pre- and post-secretory processing of peptide signals appe
ars to be mediated primarily by subtilisin-like peptidases in secretory ves
icles and/or membrane-associated neutral endopeptidases in the extracellula
r environment. This article presents both biochemical and physiological evi
dence to support a role for soluble neutral metallopeptidases in the mediat
ion of cell-to-cell communication by the selective generation and terminati
on of peptide signals. These soluble peptidases have been implicated in the
normal and disease-state processing of peptides involved in neurological,
endocrine and cardiovascular functions. In this context, specific inhibitor
s of these enzymes could selectively modulate peptide levels and thus have
considerable therapeutic potential. The aim of this review is to discuss th
e design and development of specific inhibitors of soluble neutral metallop
eptidases that have been instrumental in identifying the roles of these enz
ymes. It will also review the evidence and present a case for the involveme
nt of soluble neutral metallopeptidases in the regulation of peptide signal
ling in both central nervous system [CNS) and peripheral tissues. Copyright
(C) 2000 European Peptide Society and John Wiley gr Sons, Ltd.